Cargando…
High‐Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long‐Term Outcomes
BACKGROUND: The associations between high‐sensitivity troponin I (hsTnI) levels and coronary artery disease (CAD) severity and progression remain unclear. We investigated whether there is an association between hsTnI and angiographic severity and progression of CAD and whether the predictive value o...
Autores principales: | Samman Tahhan, Ayman, Sandesara, Pratik, Hayek, Salim S., Hammadah, Muhammad, Alkhoder, Ayman, Kelli, Heval M., Topel, Matthew, O'Neal, Wesley T., Ghasemzadeh, Nima, Ko, Yi‐An, Gafeer, Mohamad Mazen, Abdelhadi, Naser, Choudhary, Fahad, Patel, Keyur, Beshiri, Agim, Murtagh, Gillian, Kim, Jonathan, Wilson, Peter, Shaw, Leslee, Vaccarino, Viola, Epstein, Stephen E., Sperling, Laurence, Quyyumi, Arshed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866331/ https://www.ncbi.nlm.nih.gov/pubmed/29467150 http://dx.doi.org/10.1161/JAHA.117.007914 |
Ejemplares similares
-
The Prognostic Significance of Diabetes and Microvascular Complications in Patients With Heart Failure With Preserved Ejection Fraction
por: Sandesara, Pratik B., et al.
Publicado: (2018) -
Living in Food Deserts and Adverse Cardiovascular Outcomes in Patients With Cardiovascular Disease
por: Kelli, Heval M., et al.
Publicado: (2019) -
Diastolic Blood Pressure and Adverse Outcomes in the TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist) Trial
por: Sandesara, Pratik B., et al.
Publicado: (2018) -
Cohort profile: the Emory Cardiovascular Biobank (EmCAB)
por: Ko, Yi-An, et al.
Publicado: (2017) -
Soluble Urokinase‐Type Plasminogen Activator Receptor and High‐Sensitivity Troponin Levels Predict Outcomes in Nonobstructive Coronary Artery Disease
por: Al‐Badri, Ahmed, et al.
Publicado: (2020)